Color IPO

Color is a health technology company that provides genetic testing, COVID-19 testing, and population health programs primarily through partnerships with employers, health systems, and government agencies. The company initially focused on making genetic testing for hereditary cancer and heart disease more accessible and affordable, but has since expanded into broader population health initiatives. Color's platform combines laboratory services with software tools that help healthcare providers and organizations manage large-scale testing and screening programs.

During the COVID-19 pandemic, Color pivoted quickly to become one of the largest providers of COVID-19 testing in the United States, processing millions of tests and developing the logistics infrastructure to support large-scale public health initiatives. This experience has positioned the company as a key player in population health management, with capabilities that extend beyond genetic testing to include infectious disease monitoring, chronic disease screening, and health data analytics. Color's technology platform enables organizations to implement comprehensive health programs while maintaining clinical quality and regulatory compliance.